Spectroscopy-supported frame-based image-guided stereotactic biopsy of parenchymal brain lesions: Comparative evaluation of diagnostic yield and diagnostic accuracy

Clinical Neurology and Neurosurgery

Volumn 111, Issue 6, 2009, Pages 527-535

  Chernov, Mikhail F ^a   Muragaki, Yoshihiro ^a   Ochiai, Taku ^a   Taira, Takaomi ^a   Ono, Yuko ^a   Usukura, Masao ^a   Maruyama, Takashi ^a   Nakaya, Kotaro ^a   Nakamura, Ryoichi ^a   Iseki, Hiroshi ^a   Kubo, Osami ^a   Hori, Tomokatsu ^a   Takakura, Kintomo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Brain tumor; Diagnostic accuracy; Diagnostic yield; Metabolic imaging; Proton magnetic resonance spectroscopy; Stereotactic biopsy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN CANCER; BRAIN INFARCTION; BRAIN TUMOR; CANCER GRADING; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENCEPHALITIS; FEMALE; GERM CELL TUMOR; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEURORADIOLOGY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOTACTIC BIOPSY;

ADOLESCENT; ADULT; AGED; BIOPSY; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STEREOTAXIC TECHNIQUES;

EID: 67349145333     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.03.006     Document Type: Article

References (65)

1. Blaauw G., and Braakman R. Pitfalls in diagnostic stereotactic brain surgery. Acta Neurochir Suppl 42 (1988) 161-165
2. Voges J., Schroder R., Treuer H., Pastyr O., Schlegel W., Lorenz W.J., et al. CT-guided and computer assisted stereotactic biopsy: technique, results, indications. Acta Neurochir (Wien) 125 (1993) 142-149
3. Soo T.M., Bernstein M., Provias J., Tasker R., Lozano A., and Guha A. Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurg 64 (1996) 183-196
4. Hall W.A. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 82 (1998) 1749-1755
5. Fontaine D., Dormont D., Hasboun D., Clemenceau S., Valery C., Oppenheim C., et al. Magnetic resonance-guided stereotactic biopsies: results in 100 consecutive cases. Acta Neurochir (Wien) 142 (2000) 249-256
6. Yu X., Liu Z., Tian Z., Li S., Huang H., Xiu B., et al. Stereotactic biopsy for intracranial space-occupying lesions: clinical analysis of 550 cases. Stereotact Funct Neurosurg 75 (2000) 103-108
7. Jackson R.J., Fuller G.N., Abi-Said D., Lang F.F., Gokaslan Z.L., Shi W.M., et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neurooncology 3 (2001) 193-200
8. Kim J.E., Kim D.G., Paek S.H., and Jung H.W. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir (Wien) 145 (2003) 547-555
9. Takahashi H., Sugai T., Uzuka T., Kano M., Honma J., Grinev I., et al. Complications and diagnostic yield of stereotactic biopsy for the patients with malignant brain tumors. No Shinkei Geka 32 (2004) 135-140 (in Japanese)
10. Yamada K., Goto S., Kochi M., and Ushio Y. Stereotactic biopsy for multifocal, diffuse, and deep-seated brain tumors using Leksell's system. J Clin Neurosci 11 (2004) 263-267
11. Aker F.V., Hakan T., Karadereler S., and Erkan M. Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens. Neuropathology 25 (2005) 207-213
12. Heper A.O., Erden E., Savas A., Ceyhan K., Erden I., Akyar S., et al. An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study. Surg Neurol 64 Suppl. 2 (2005) S82-S88
13. Jain D., Sharma M.C., Sarkar C., Deb P., Gupta D., and Mahapatra A.K. Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion. Brain Tumor Pathol 23 (2006) 71-75
14. Setzer M., Herminghaus S., Marquardt G., Tews D.S., Pilatus U., Seifert V., et al. Diagnostic impact of proton MR-spectroscopy versus image-guided stereotactic biopsy. Acta Neurochir (Wien) 149 (2007) 379-386
15. Kleihues P., Volk B., Anagnostopoulos J., and Kiessling M. Morphologic evaluation of stereotactic brain tumour biopsies. Acta Neurochir Suppl 33 (1984) 171-181
16. Chandrasoma P.T., Smith M.M., and Apuzzo M.L.J. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 24 (1989) 160-165
17. Feiden W., Steude U., Bise K., and Gundisch O. Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg Rev 14 (1991) 51-56
18. McGirt M.J., Villavicencio A.T., Bulsara K.R., and Friedman A.H. MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol 59 (2003) 277-282
19. 18F]fluorodeoxyglucose. J Neurosurg 82 (1995) 445-452
20. Croteau D., Scarpace L., Hearshen D., Gutierrez J., Fisher J.L., Rock J.P., et al. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49 (2001) 823-829
21. Law M., Yang S., Wang H., Babb J.S., Johnson G., Cha S., et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24 (2003) 1989-1998
22. Pirotte B., Goldman S., Salzberg S., Wikler D., David P., Vandesteene A., et al. Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases. Pediatr Neurosurg 38 (2003) 146-155
23. Maia Jr. A.C.M., Malheiros S.M.F., da Rocha A.J., Stavale J.N., Guimaraes I.F., Borges L.R.R., et al. Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. J Neurosurg 101 (2004) 970-976
24. 18F]fluoroethyl-l-tyrosine and magnetic resonance spectroscopy. J Neurosurg 102 (2005) 318-327
25. Maia A.C.M., Malheiros S.M.F., da Rocha A.J., da Silva C.J., Gabbai A.A., Ferraz F.A.P., et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 26 (2005) 777-783
26. Rollin N., Guyotat J., Streichenberger N., Honnorat J., Tran Minh V.-A., and Cotton F. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48 (2006) 150-159
27. Hanson M.W., Glantz M.J., Hoffman J.M., Friedman A.H., Burger P.C., Schold S.C., et al. FDG-PET in the selection of brain lesions for biopsy. J Comput Assist Tomogr 15 (1991) 796-801
28. Levivier M., Goldman S., Bidaut L., Luxen A., Stanus E., Przedborski S., et al. Proton emission tomography-guided stereotactic brain biopsy. Neurosurgery 31 (1992) 792-797
29. Maciunas R.J., Kessler R.M., Maurer C., Mandava V., Watt G., and Smith G. Positron emission tomography imaging-directed stereotactic neurosurgery. Stereotact Funct Neurosurg 58 (1992) 134-140
30. Pirotte B., Goldman S., David P., Wikler D., Damhaut P., Vandesteene A., et al. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine. Acta Neurochir Suppl 68 (1997) 133-138
31. Massager N., David P., Goldman S., Pirotte B., Wikler D., Salmon I., et al. Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Neurosurg 93 (2000) 951-957
32. Messing-Junger A.M., Floeth F.W., Pauleit D., Reifenberger G., Willing R., Gartner J., et al. Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas. Childs Nerv Syst 18 (2002) 445-449
33. 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 99 (2003) 474-479
34. Hemm S., Vayssiere N., Zanca M., Ravel P., and Coubes P. Thallium SPECT-based stereotactic targeting for brain tumor biopsies. Stereotact Funct Neurosurg 82 (2004) 70-76
35. Hall W.A., Martin A., Liu H., and Truwit C.L. Improving diagnostic yield in brain biopsy: coupling spectroscopic targeting with real-time needle placement. J Magn Reson Imaging 13 (2001) 12-15
36. Martin A.J., Liu H., Hall W.A., and Truwit C.L. Preliminary assessment of turbo spectroscopic imaging for targeting in brain biopsy. AJNR Am J Neuroradiol 22 (2001) 959-968
37. 1H CSI)-directed stereotactic biopsy. Acta Neurochir (Wien) 143 (2001) 45-50
38. Rock J.P., Hearshen D., Scarpace L., Croteau D., Gutierrez J., Fisher J.L., et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51 (2002) 912-920
39. Rock J.P., Scarpace L., Hearshen D., Gutierrez J., Fisher J.L., Rosenblum M., et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54 (2004) 1111-1119
40. Ganslandt O., Stadlbauer A., Fahlbusch R., Kamada K., Buslei R., Blumcke I., et al. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density. Neurosurgery 56 Suppl. 2) (2005) 291-298
41. Hall W.A., and Truwit C.L. 1.5 T: spectroscopy-supported brain biopsy. Neurosurg Clin N Am 16 (2005) 165-172
42. McKnight T.R., Lamborn K.R., Love T.D., Berger M.S., Chang S., Dillon W.P., et al. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and Grades III gliomas. J Neurosurg 106 (2007) 660-666
43. Sibtain N.A., Howe F.A., and Saunders D.E. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol 62 (2007) 109-119
44. 1H-chemical-shift imaging of choline. Stereotact Funct Neurosurg 86 (2008) 300-307
45. Ng W.H., and Lim T. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy. J Clin Neurosci 15 (2008) 502-506
46. Muragaki Y., Chernov M., Maruyama T., Ochiai T., Taira T., Kubo O., et al. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?. Minim Invasive Neurosurg 51 (2008) 275-279
47. In: Louis D.N., Ohgaki H., Wiestler O.D., and Cavenee W.K. (Eds). WHO Classification of Tumours of the Central Nervous System (2007), IARC, Lyon
48. Mork S.J., Halvorsen T.B., Lindegaard K.-F., and Eide G.E. Oligodendroglioma: histologic evaluation and prognosis. J Neuropathol Exp Neurol 45 (1986) 65-78
49. Muragaki Y., Iseki H., Maruyama T., Kawamata T., Yamane F., Nakamura R., et al. Usefulness of intraoperative magnetic resonance imaging for glioma surgery. Acta Neurochir Suppl 98 (2006) 67-75
50. Kelly P.J., Daumas-Duport C., Kispert D.B., Kall B.A., Scheithauer B.W., and Illig J. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66 (1987) 865-874
51. Greene G.M., Hitchon P.W., Schelper R.L., Yuh W., and Dyste G.N. Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg 71 (1989) 494-497
52. Negendank W.G., Sauter R., Brown T.R., Evelhoch J.L., Falini A., Gotsis E.D., et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84 (1996) 449-458
53. Shimizu H., Kumabe T., Tominaga T., Kayama T., Hara K., Ono Y., et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 17 (1996) 737-747
54. Tedeschi G., Lundbom N., Raman R., Bonavita S., Duyn J.H., Alger J.R., et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87 (1997) 516-524
55. Meyerand M.E., Pipas J.M., Mamourian A., Tosteson T.D., and Dunn J.F. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol 20 (1999) 117-123
56. Shimizu H., Kumabe T., Shirane R., and Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21 (2000) 659-665
57. Tamiya T., Kinoshita K., Ono Y., Matsumoto K., Furuta T., and Ohmoto T. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 42 (2000) 333-338
58. Moller-Hartmann W., Herminghaus S., Krings T., Marquardt G., Lanfermann H., Pilatus U., et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44 (2002) 371-381
59. Calvar J.A., Meli F.J., Romero C., Calcagno M.L., Yanez P., Martinez A.R., et al. Characterization of brain tumors by MRS, DWI and Ki-67 labeling index. J Neurooncol 72 (2005) 273-280
60. Preul M.C., Leblanc R., Caramanos Z., Kasrai R., Narayanan S., and Arnold D.L. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases. Can J Neurol Sci 25 (1998) 13-22
61. Stadlbauer A., Moser E., Gruber S., Nimsky C., Fahlbusch R., and Ganslandt O. Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. J Neurosurg 101 (2004) 287-294
62. Dowling C., Bollen A.W., Noworolski S.M., McDermott M.W., Barbaro N.M., Day M.R., et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 22 (2001) 604-612
63. Burtscher I.M., Skagerberg G., Geijer B., Englund E., Stahlberg F., and Holtas S. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 21 (2000) 84-93
64. 1H-MRS). Neuroradiol J 21 (2008) 338-349
65. Chernov M.F., Hayashi M., Izawa M., Usukura M., Yoshida S., Ono Y., et al. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases. Brain Tumor Pathol 23 (2006) 19-27